Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $91.9525 (-1.1%) ($91.9525 - $93.5879) on Sat. Dec. 30, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.17% (three month average) | RSI | 57 | Latest Price | $91.9525(-1.1%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.3% a day on average for past five trading days. | Weekly Trend | ABBV advances 0.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting ABBV price | ABBV will decline at least -0.585% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.585% (StdDev 1.17%) | Hourly BBV | 0 () | Intraday Trend | -1.5% | | | |
|
Resistance Level | $92.07 | 5 Day Moving Average | $92.9(-1.02%) | 10 Day Moving Average | $92.93(-1.05%) | 20 Day Moving Average | $92.07(-0.13%) | To recent high | -1.5% | To recent low | 8.6% | Market Cap | $N/A | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |